72 results in Exploration of Targeted Anti-tumor Therapy
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Original Article
Genomic alterations in the WNT/β-catenin pathway and resistance of colorectal cancer cells to pathway-targeting therapies
Ioannis A. Voutsadakis
Published: February 25, 2025 Explor Target Antitumor Ther. 2025;6:1002295
Open Access
Review
Unmasking the potential: mechanisms of neuroinflammatory modulation by oncolytic viruses in glioblastoma
Narimene Beder ... Mehdi Totonchi
Published: February 24, 2025 Explor Target Antitumor Ther. 2025;6:1002294
Open Access
Meta-Analysis
Elacestrant in hormone receptor-positive metastatic breast cancer: a post-hoc analysis
Azza Sarfraz ... Khadija Cheema
Published: February 20, 2025 Explor Target Antitumor Ther. 2025;6:1002293
Open Access
Review
Releasing the brakes: the role of immune checkpoint inhibitors in laryngeal cancer
Michail Athanasopoulos ... Nicholas S. Mastronikolis
Published: February 17, 2025 Explor Target Antitumor Ther. 2025;6:1002292
This article belongs to the special issue Immune Checkpoint Therapy and Biomarkers in Cancer
Open Access
Review
Multikinase and highly selective kinase inhibitors in the neoadjuvant treatment of patients with thyroid cancer
Laura Valerio, Antonio Matrone
Published: February 13, 2025 Explor Target Antitumor Ther. 2025;6:1002291
This article belongs to the special issue Advances in Cancer Genomics and Therapeutic Targets
Open Access
Systematic Review
Non-targeted effects of stereotactic radiotherapy: a review of the evidence coming from the clinical field
Angela Barillaro ... Roberto Pacelli
Published: February 13, 2025 Explor Target Antitumor Ther. 2025;6:1002290
This article belongs to the special issue Use of Different Radiation Treatment Modalities in Cancer Therapy: The Role of Inflammation and Immune Response
Open Access
Meta-Analysis
Shorter telomere length as a prognostic marker for survival and recurrence in breast cancer: a systematic review and meta-analysis
Dhyas Munandar Arya Sasmita ... Sumadi Lukman Anwar
Published: February 13, 2025 Explor Target Antitumor Ther. 2025;6:1002289
Open Access
Review
Neoantigen immunotherapy: a novel treatment for bladder cancer
Ruiyang Lv ... Xuejian Wang
Published: January 26, 2025 Explor Target Antitumor Ther. 2025;6:1002288
Open Access
Original Article
Concomitant exposure to benzodiazepines during pembrolizumab-based therapy for advanced non-small-cell lung cancer: a propensity-score matched analysis of monitoring agency data
Fabrizio Nelli ... Agnese Fabbri
Published: January 20, 2025 Explor Target Antitumor Ther. 2025;6:1002287
This article belongs to the special issue Immune Checkpoint Therapy and Biomarkers in Cancer
Open Access
Perspective
Implications of noncoding RNAs for cancer therapy: Are we aiming at the right targets?
Amil Shah
Published: January 16, 2025 Explor Target Antitumor Ther. 2025;6:1002286
This article belongs to the special issue Advances in Cancer Genomics and Therapeutic Targets
Open Access
Review
Herbal based nanoparticles as a possible and potential treatment of cancer: a review
Roshan Yadav ... Tejpal Yadav
Published: January 03, 2025 Explor Target Antitumor Ther. 2025;6:1002285
This article belongs to the special issue Potential Clinical Applications of Inorganic Nanomaterials in Cancer
Open Access
Original Article
Assessment of lipid peroxidation and total antioxidant capacity in patients with breast cancer
Abdullatif Taha Babakr, Mohamed Mahmoud Nour Eldein
Published: January 02, 2025 Explor Target Antitumor Ther. 2025;6:1002284
Previous